Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.

Kent S. et al, (2019), Pharmacoeconomics

The clinical and cost-effectiveness of total versus partial knee replacement in patients with medial compartment osteoarthritis (TOPKAT): 5-year outcomes of a randomised controlled trial.

Beard DJ. et al, (2019), Lancet

Impact of achieving primary care targets in Type 2 diabetes on health outcomes and healthcare costs.

Keng MJ. et al, (2019), Diabetes Obes Metab

Impact of a National Enhanced Recovery After Surgery Programme on Patient Outcomes of Primary total Knee Replacement: an Interrupted Time Series Analysis from "The National Joint Registry of England, Wales, Northern Ireland and the Isle of Man".

Garriga C. et al, (2019), Osteoarthritis Cartilage

Delayed Hospital Discharges of Older Patients: A Systematic Review on Prevalence and Costs.

Landeiro F. et al, (2019), Gerontologist, 59, e86 - e97

Correction to: The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study.

Leal J. et al, (2019), Pharmacoeconomics

Decision models of prediabetes populations: a systematic review.

Leal J. et al, (2019), Diabetes Obes Metab

Impact of variation in Type 2 diabetes care on health outcomes and healthcare costs

Keng MJ. et al, (2019), DIABETIC MEDICINE, 36, 161 - 161

Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)

(2019), Diabetologia

Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathy.

Leal J. et al, (2018), Eye (Lond)

Physiotherapy Rehabilitation for Osteoporotic Vertebral Fracture - A randomised controlled trial and economic evaluation (PROVE trial): ISRCTN 49117867

Barker K. et al, (2018), JOURNAL OF BONE AND MINERAL RESEARCH, 33, 21 - 21

Risk attitudes of people with 'manageable' chronic disease: An analysis under prospect theory.

Rouyard T. et al, (2018), Soc Sci Med, 214, 144 - 153

Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL

Reed SD. et al, (2018), DIABETOLOGIA, 61, S426 - S426

Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial

Becker F. et al, (2018), DIABETOLOGIA, 61, S366 - S366

Repercussion of a national intervention on patient outcomes of primary knee arthroplasty to enhance the recovery pathway: 2008-2016 England trends

Garriga C. et al, (2018)

Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).

Reed SD. et al, (2018), Diabetes Obes Metab, 20, 1732 - 1739

Nudging people with Type 2 diabetes towards better self-management through personalized risk communication: A pilot randomized controlled trial in primary care.

Rouyard T. et al, (2018), Endocrinol Diabetes Metab, 1

EXSCEL-Once-Weekly Exenatide Reduces Medical Resource Utilization in Patients with Type 2 Diabetes Mellitus

Reed SD. et al, (2018), DIABETES, 67

Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.

Palmer AJ. et al, (2018), Value Health, 21, 724 - 731

The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study.

Leal J. et al, (2018), Pharmacoeconomics

Load More

Include forthcoming?